Drugs for HER-2-positive breast cancer

Growth factor receptors have long been known to drive malignant transformation and cancer progression. The epidermal growth factor receptor (EGFR, ErbB, HER) system is likely the best described membrane receptor tyrosine kinase family in malignant tumors. With implementation of the growth-inhibitory...

Full description

Saved in:
Bibliographic Details
Main Authors: Sibilia, Maria., Zielinski, Christoph C., Bartsch, Rupert., Grunt, Thomas W.
Format: Livro
Language:Inglês
Published: Springer, 2011
Series:Milestones in Drug Therapy,
Subjects:
Farmacologia.
Oncologia.
Câncer Pesquisa.
Anticorpos.
Imunologia.
Medicina interna.
Online Access:https://minerva.ufrj.br/F/?func=direct&doc_number=000895504&local_base=UFR01
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items